Paul-Ehrlich-Institut

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Immunological Medicines for Cattles

Immunological veterinary medicinal products, including vaccines, are authorised for cattle.

Search results 1 to 25 from a total of 65

Name De­scrip­tion Mar­ket­ing Au­tho­ri­sa­tion Hold­er Li­cense Num­ber Li­cense Date An­i­mal Further Information

Rispoval IBR-Marker vivum

BHV1-Infektion

Zoetis Deutschland GmbH

496a/93 28.10.1994 Rind

Hiprabovis IBR Marker Live

BHV1-Infektion

Laboratorios Hipra S.A., Spanien

EU/2/10/114/001-002 27.01.2011 Rind

EPAR: Hiprabovis IBR Marker Live

Rispoval IBR-Marker inactivatum

BHV1-Infektion

Zoetis Deutschland GmbH

497a/93 28.10.1994 Rind

Bovilis IBR Marker live

BHV1-Infektion

Intervet Deutschland GmbH

PEI.V.11616.01.1 02.02.2012 Rind

Bovilis IBR Marker inac

BHV1-Infektion

Intervet Deutschland GmbH

PEI.V.03246.01.1 23.09.2005 Rind

Syvazul BTV 3

Blauzungenkrankheit, Serotyp 3

Laboratorios Syva S.A., Spanien

EU/2/24/332 20.02.2025 Schaf, Rind

EPAR: Syvazul BTV 3

Bluevac-3

Blauzungenkrankheit, Serotyp 3

CZ Vaccines S.A.U., Spanien

EU/2/24/331 20.02.2025 Schaf, Rind

EPAR: Bluevac-3

Bluevac-4

Blauzungenkrankheit, Serotyp 4

CZ Veterinaria S.A., Spanien

PEI.V.11839.01.1 25.05.2016 Schaf, Rind

Bluevac BTV

Blauzungenkrankheit, Serotyp 8, 4 oder 1

CZ Veterinaria S.A., Spanien

EU/2/11/122/001-003 14.04.2011 Schaf, Rind

EPAR: Bluevac BTV

Zulvac 1+8 Bovis

Blauzungenkrankheit, Serotypen 1 und 8

Zoetis Belgium S.A., Belgien

EU/2/12/139/001-003 08.03.2012 Rind

EPAR: Zulvac 1+8 Bovis

BTVPUR

Blauzungenkrankheit, Serotypen 1, 2, 4 oder 8

Boehringer Ingelheim Vetmedica GmbH

EU/2/10/113/001-050 17.12.2010 Rind, Schaf

EPAR: BTVPUR

Zulvac BTV

Blauzungenkrankheit, Serotypen 1, 4 oder 8

Zoetis Belgium S.A., Belgien

EU/2/17/207/001-009 25.04.2017 Rind, Schaf

EPAR: Zulvac BTV Ovis

SYVAZUL BTV

Blauzungenkrankheit, Serotypen 1, 4 oder 8

Laboratorios Syva, S.A.U., Spanien

EU/2/18/231/001-012 09.01.2019 Schaf, Rind

EPAR: Syvazul BTV

DIVENCE TETRA

Bovine Virusdiarrhoe, Bovine Parainfluenza, Bovines Respiratorisches Synzytialvirus

Laboratorios Hipra, S.A., Spanien

EU/2/24/310 10.05.2024 Rind

EPAR: DIVENCE TETRA

DIVENCE PENTA

Bovine Virusdiarrhoe, Bovine Parainfluenza, Bovines Respiratorisches Synzytialvirus, Bovines Herpesvirus

Laboratorios Hipra, S.A., Spanien

EU/2/24/307 10.04.2024 Rind

EPAR: DIVENCE PENTA

DIVENCE IBR Marker Live

Bovines Herpesvirus

Laboratorios Hipra, S.A., Spanien

EU/2/24/318 20.08.2024 Rind

EPAR: DIVENCE IBR Marker Live

Rispoval RS

BRSV-Infektion

Zoetis Deutschland GmbH

116a/89 28.10.2005 Rind

NASYM

BRSV-Infektion

Laboratorios Hipra S.A., Spanien

EU/2/19/241 29.07.2019 Rind

Rispoval RS+PI3 IntraNasal

BRSV-Infektion,
Parainfluenza-3

Zoetis Deutschland GmbH

PEI.V.03416.01.1 15.08.2006 Rind

Rispoval 3-BRSV-PI3-BVD

BRSV-Infektion,
Parainfluenza-3,
BVD/MD

Zoetis Deutschland GmbH

PEI.V.03128.01.1 21.04.2005 Rind

Rispoval 2 / BRSV + Pi3

BRSV-Infektion, Bovine Parainfluenza

Zoetis Deutschland GmbH

PEI.V.12018.01.1 18.11.2020 Rind

Bovilis IntraNasal RSP Live

BRSV-Infektion, Bovine Parainfluenza

Intervet Deutschland GmbH

PEI.V.11976.01.1 18.05.2019 Rind

BOVALTO Respi Intranasal

BRSV-Infektion, Parainfluenza-3

Boehringer Ingelheim Vetmedica GmbH

PEI.V.11947.01.1 19.03.2018 Rind

Mucosiffa

BVD/MD

Ceva Tiergesundheit GmbH

PEI.V.03518.01.1 06.03.2008 Rind

Bovela

BVD/MD

Boehringer Ingelheim Vetmedica GmbH

EU/2/14/176/001-016 22.12.2014 Rind

EPAR: Bovela

Disclaimer

The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.

The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.

As of: PEI announcement No. 530 in BAnz AT 16.06.2025 B4.

Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)

Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.

If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.

Updated: 17.06.2025